Prev：Exploring the protective mechanisms of syringaresinol against myocardial infarction by experimental validation and network pharmacology.(KTA0002-)
Next：Apolipoprotein A-1 Antisense RNA Exacerbates Atherosclerosis by Targeting MicroRNA-185.(KTA0002-1.1001)
